Unknown

Dataset Information

0

Epicutaneous Tolerance Induction to a Bystander Antigen Abrogates Colitis and Ileitis in Mice.


ABSTRACT: BACKGROUND:Although inflammatory bowel disease (IBD) is a failure in maintaining tolerance to the intestinal microbiota, few studies have investigated the use of immunologic tolerance as a treatment approach for IBD. We hypothesized that induction of immune tolerance at a distal site could suppress intestinal inflammation through a process of bystander regulation. METHODS:Epicutaneous tolerance was induced by topical application of ovalbumin (OVA) using a Viaskin patch for 48 hours. In some experiments, a single feed of ovalbumin was used to drive epicutaneous tolerance-induced regulatory T cells (Tregs) to the intestine. The mechanism of tolerance induction was tested using neutralizing antibodies against TGF-?, IL-10, and Treg depletion using Foxp3-DTR mice. The capacity of skin-draining Tregs, or epicutaneous tolerance, to prevent or treat experimental IBD was tested using T-cell transfer colitis, dextran sodium sulfate (DSS) colitis, and ileitis in SAMP-YITFc mice. Weight loss, colonic inflammatory cytokines and histology were assessed. RESULTS:Epicutaneous exposure to ovalbumin induced systemic immune tolerance by a TGF-?-dependent, but IL-10 and iFoxp3 Treg-independent mechanism. Skin draining Tregs suppressed the development of colitis. Epicutaneous tolerance to a model antigen prevented intestinal inflammation in the dextran sodium sulfate and SAMP-YITFc models and importantly could halt disease in mice already experiencing weight loss in the T-cell transfer model of colitis. This was accompanied by a significant accumulation of LAP and Foxp3 Tregs in the colon. CONCLUSIONS:This is the first demonstration that epicutaneous tolerance to a model antigen can lead to bystander suppression of inflammation and prevention of disease progression in preclinical models of IBD.

SUBMITTER: Dunkin D 

PROVIDER: S-EPMC5659741 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Background</h4>Although inflammatory bowel disease (IBD) is a failure in maintaining tolerance to the intestinal microbiota, few studies have investigated the use of immunologic tolerance as a treatment approach for IBD. We hypothesized that induction of immune tolerance at a distal site could suppress intestinal inflammation through a process of bystander regulation.<h4>Methods</h4>Epicutaneous tolerance was induced by topical application of ovalbumin (OVA) using a Viaskin patch for 48 hour  ...[more]

Similar Datasets

| S-EPMC6585762 | biostudies-literature
| S-EPMC4019192 | biostudies-literature
| S-EPMC5354461 | biostudies-literature
| S-EPMC3105371 | biostudies-literature
| S-EPMC2886150 | biostudies-literature
| S-EPMC5826312 | biostudies-literature
| S-EPMC7016002 | biostudies-literature
| S-EPMC7550404 | biostudies-literature
| S-EPMC3749436 | biostudies-literature
| S-EPMC7372932 | biostudies-literature